Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
Want to see JP:4531 full AI Analyst Report?
4531 Stock Chart & Stats
¥317.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥317.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥256.00 - ¥640.00
Previous CloseN/A
Volume43.40K
Average Volume (3M)39.67K
Market Cap
¥7.92B
Enterprise Value¥13.52B
Total Cash (Recent Filing)¥1.05B
Total Debt (Recent Filing)¥9.06B
Price to Earnings (P/E)25.4
Beta0.96
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.97%
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,974,000
10 Day Avg. Volume32,460
30 Day Avg. Volume39,673
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)0.62
Price to Sales (P/S)0.55
P/FCF Ratio4.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue GrowthSustained multi-year revenue expansion into 2025 shows underlying demand for the firm's specialty chemicals across pharma, agriculture and industrial end-markets. That track record supports customer relationships, scale advantages and continued product development leverage even if near-term sales softened.
Balance-sheet StabilityEquity consistently exceeding total debt and moderate historical leverage provide a structural buffer against cyclical shocks. This capital structure supports continued operations, capacity to fund targeted investments or working capital needs, and preserves strategic optionality over the medium term.
2026 Cash Generation ReboundThe jump to strong operating cash flow and positive free cash flow in 2026 materially improves the firm's ability to self-fund working capital and reinvest in specialty chemistry capabilities. If sustained, this enhances financial flexibility and reduces reliance on external financing for growth and capex.
Bears Say
Sharp 2026 Earnings DeclineA large, single-year drop in net income materially weakens internal profitability and cash accrual capacity. Persistent margin pressure or recurring earnings weakness would erode return on capital, limit funding for R&D and capex, and could force tougher cost or pricing responses across core specialty product lines.
Historically Inconsistent Free Cash FlowMulti-year negative free cash flow through 2023–2025 indicates the company previously failed to generate enough internal cash to fund investments. That pattern raises questions about the durability of the 2026 improvement and suggests higher reliance on external capital during downcycles, weakening long-term financial resilience.
Rising And Elevated DebtAn increase in absolute debt and elevated leverage heighten financial risk, especially alongside the 2026 earnings drop. Higher debt raises interest and covenant exposure, constrains capital allocation flexibility, and magnifies downside if margins or cash flows deteriorate further in the medium term.
Yuki Gosei Kogyo Co., Ltd. News
4531 FAQ
What was Yuki Gosei Kogyo Co., Ltd.’s price range in the past 12 months?
Yuki Gosei Kogyo Co., Ltd. lowest stock price was ¥256.00 and its highest was ¥640.00 in the past 12 months.
What is Yuki Gosei Kogyo Co., Ltd.’s market cap?
Yuki Gosei Kogyo Co., Ltd.’s market cap is ¥7.92B.
When is Yuki Gosei Kogyo Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Yuki Gosei Kogyo Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is Yuki Gosei Kogyo Co., Ltd. overvalued?
According to Wall Street analysts Yuki Gosei Kogyo Co., Ltd.’s price is currently Overvalued.
Does Yuki Gosei Kogyo Co., Ltd. pay dividends?
Yuki Gosei Kogyo Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 2.97%. See more information on Yuki Gosei Kogyo Co., Ltd. dividends here
What is Yuki Gosei Kogyo Co., Ltd.’s EPS estimate?
Yuki Gosei Kogyo Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yuki Gosei Kogyo Co., Ltd. have?
Yuki Gosei Kogyo Co., Ltd. has 21,974,000 shares outstanding.
What happened to Yuki Gosei Kogyo Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Yuki Gosei Kogyo Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4531
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
Technical Analysis
NANKAI CHEMICAL COMPANY LIMITED
―
Nippon Soda Co., Ltd.
―
Toho Acetylene Co., Ltd.
―
Daito Chemix Corporation
―
Toyo Gosei Co., Ltd.
―